1,157 results on '"Deckert, J"'
Search Results
102. A brain area for catastrophizing
103. P.048 Results of the predict randomised controlled trial: clinical effects of using the predict test to guide antidepressant treatment in depression
104. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients – support for the glutamate hypothesis of schizophrenias
105. A major role for common genetic variation in anxiety disorders
106. PMH21 COST-EFFECTIVENESS OF THE PREDICT TEST: RESULTS AND LESSONS LEARNED FROM A EUROPEAN MULTINATIONAL DEPRESSION TRIAL
107. Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood
108. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease
109. INVESTIGATION OF RGS2 AND RGS13 GENE POLYMORPHISMS IN HUMAN PANIC DISORDER
110. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder
111. Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks
112. Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia
113. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci
114. Serotonergic genes modulate amygdala activity in major depression
115. The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features
116. An adenosine A2A receptor gene haplotype is associated with migraine with aura
117. Abstracts Second Congress of the European Society for Clinical Neuropharmacology: Würzburg, November 9–11, 1995
118. INVESTIGATION OF RGS2 AND RGS13 GENE POLYMORPHISMS IN HUMAN PANIC DISORDER
119. Investigation of the DAOA/G30 locus in panic disorder
120. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci
121. Post- and presynaptic lesions in the CA1 region of hippocampus: Effect on [3H]forskolin and [3H]phorboldibutyrate ester binding
122. Nimodipin in der Behandlung des Alkoholentzugsyndroms: Erfahrungen aus einer offenen Studie
123. Mapping of the human adenosine A2a receptor gene: relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region
124. Methyl- and acetyltransferases are stable epigenetic markers postmortem
125. Increased fear learning, spatial learning as well as neophobia in Rgs2(-/-) mice
126. P5450Evening levels and circadian changes of salivary cortisol predict adverse events in heart failure patients with comorbid depression - a MOOD-HF substudy
127. Influence of two functional polymorphisms in NOS1 on baseline cortisol and working memory in healthy subjects
128. Variations in cardiovascular risk factors in people with and without migration background in Germany – Results from the STAAB cohort study
129. Influence of two functional polymorphisms in nitric oxide synthase 1 on baseline cortisol and working memory in healthy subjects
130. Increased C-reactive protein concentrations is associated with increased concentrations of quetiapine
131. Serotonin transporter gene hypermethylation – an epigenetic footprint of depressive symptomatology in panic disorder?
132. Monoamine Oxidase A (MAOA) methylation in acrophobia: an epigenetic correlate of therapy response?
133. Childhood trauma dependent anxious depression sensitizes HPA axis function
134. Therapeutic drug level measurement in breast milk
135. Sonstige Psychopharmaka
136. Wodarz et al reply: Do musical hallucinations have a neurological cause?
137. A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety
138. Prof. Dr. med. Helmut Beckmann: 22.05.1940–03.09.2006
139. A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety
140. Differences in the pharmacokinetics of psychopharmacological drugs between smokers and nonsmokers
141. Corrigendum to “LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease” [BBAPAP 1865 (6) (2017) 703–714]
142. Hypermethylation of the monoamine oxidase A gene – a new epigenetic marker for posttraumatic stress disorder?
143. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
144. Erratum: A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing
145. The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial.
146. GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder
147. Benzodiazepinliganden im Liquor cerebrospinalis
148. Central Sites of Adenosine Action and Their Interaction with Various Drugs
149. Investigation of RGS2 and RGS13 gene polymorphisms in human panic disorder
150. Das Forschungsnetzwerk PANIC-NET – Von einem besseren Verständnis neurobiologischer Mechanismen der Furchtregulation zu effektiverer psychotherapeutischer Behandlung in der Praxis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.